检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李强[1] 郝希山[1] 武强[1] 马维东[1] 宋天强[1] 牛昀[1]
机构地区:[1]天津医科大学附属肿瘤医院肝胆科,300060
出 处:《中华普通外科杂志》2005年第12期764-765,共2页Chinese Journal of General Surgery
摘 要:目的探讨乳腺癌肝转移外科治疗的价值。方法回顾性分析1997年5月至2000 年5月我院手术治疗的18例乳腺癌肝转移患者的治疗过程和预后情况。结果本组肝转移多发生在乳腺癌原发灶切除24~36个月以后,占66.7%,合并肝内多发转移灶者11例,单发病灶7例。 18例患者均行外科手术切除肝转移灶。单灶与多灶肝转移3年生存率分别为83.3%和54.5%(P= 0.037)。结论在无其他脏器转移时乳腺癌肝转移的外科治疗的效果与肝转移灶数目相关,与肝转移灶的体积大小,及乳腺癌原发灶的分期无相关性,积极的外科治疗是提高患者生存率的有效方法之一。Objective To evaluate hepatectomy for liver metastasis in breast cancer patients. Methods From May 1997 to May 2000, 18 primary breast cancer patients with metachronous liver metastases underwent hepatectomy. The clinicopathologic features and surgical results were analyzed. Results The actuarial 1,3-year survival rates after hepatic resection were 100% and 83.3% for patients with solitary metastasis, and 90.9% and 54.5% for those with multiple foci. Conclusions Posthepatectomy long term survival was correlated with the number of foci in postmastectomy breast cancer patients suffering from heterochronous liver metastasis. Tumor size and TNM stage of breast cancer were not correlated with the survival. Aggressive surgery helps to prolong the survival.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.147